Abattis Bioceuticals Corp.
ATTBF · OTC
9/30/2019 | 9/30/2018 | 9/30/2017 | 9/30/2016 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,061 | -$77,651 | -$7,926 | -$2,412 |
| Dep. & Amort. | $109 | $37 | $121 | $130 |
| Deferred Tax | -$707 | $17,199 | $954 | -$287 |
| Stock-Based Comp. | $2 | $495 | $719 | $68 |
| Change in WC | $8,448 | -$712 | $188 | $309 |
| Other Non-Cash | $4,621 | $52,352 | $5,676 | $1,172 |
| Operating Cash Flow | $9,412 | -$8,279 | -$1,222 | -$733 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,061 | -$234 | -$431 | -$46 |
| Net Acquisitions | -$9,851 | -$16,000 | $0 | $0 |
| Inv. Purchases | $5,000 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $3,395 | $0 | $0 | $83 |
| Other Inv. Act. | -$5,000 | $0 | -$1 | $7 |
| Investing Cash Flow | -$11,517 | -$16,234 | -$431 | $44 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $30 |
| Stock Issued | $0 | $27,577 | $2,140 | $536 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $60 | $475 | $0 | $0 |
| Financing Cash Flow | $60 | $28,052 | $2,140 | $566 |
| Forex Effect | $0 | $0 | $0 | $3 |
| Net Chg. in Cash | -$2,045 | $3,538 | $487 | -$119 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,064 | $526 | $38 | $158 |
| End Cash | $2,019 | $4,064 | $526 | $38 |
| Free Cash Flow | $4,351 | -$8,513 | -$1,653 | -$779 |